USANA Health Sciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.0% | +22.9% | -9.7% | +22.9% | -16.7% | +26.6% | -24.4% | -14.3% | -32.0% | -13.7% | -63.4% | |
| – | +13.3% | +35.1% | +19.5% | +4.5% | +36.6% | -2.2% | -1.4% | -3.5% | -4.7% | +9.0% | +46.5% | |
| – | +13.0% | +49.3% | -6.4% | -3.4% | +3.9% | -7.4% | -0.7% | -5.7% | +8.2% | -0.3% | -5.0% | |
| – | – | – | +189.7% | -53.5% | -31.3% | +5.7% | -10.1% | -44.8% | – | – | – | |
| – | -59.9% | +2.1% | -28.0% | -202.0% | – | – | -5,290.6% | – | -3,731.5% | – | – | |
| – | +16.2% | +37.8% | -59.6% | -13.5% | +44.9% | -8.9% | -15.4% | -18.5% | +39.4% | -30.5% | +37.2% | |
| – | +54.5% | +26.9% | -59.5% | +434.8% | – | -171.5% | -58.2% | -12.8% | -3.2% | +1,679.5% | -95.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -55.9% | +5.6% | -22.6% | +110.8% | +42.3% | -62.0% | +211.8% | -85.7% | -54.3% | -18.6% | +191.3% | |
| – | – | +0.0% | – | – | – | -29.2% | -100.0% | – | – | +2,705.6% | -140.5% | |
| – | -56.5% | +31.9% | -22.4% | +109.2% | +44.4% | -60.9% | +205.2% | -83.4% | -52.7% | – | -525.0% | |
| – | – | +1.5% | +119.1% | -146.7% | – | +282.6% | -192.4% | – | -12.0% | -454.8% | – | |
| – | +3.5% | +18.9% | +6.0% | +27.2% | -21.7% | +31.9% | -25.4% | -13.8% | -40.0% | -9.3% | -83.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.